@article{efd4358092e5404da4fceedff24c88d7,
title = "Power analysis for cluster randomized trials with continuous co-primary endpoints",
abstract = "Pragmatic trials evaluating health care interventions often adopt cluster randomization due to scientific or logistical considerations. Systematic reviews have shown that coprimary endpoints are not uncommon in pragmatic trials but are seldom recognized in sample size or power calculations. While methods for power analysis based on K ((Figure presented.)) binary coprimary endpoints are available for cluster randomized trials (CRTs), to our knowledge, methods for continuous coprimary endpoints are not yet available. Assuming a multivariate linear mixed model (MLMM) that accounts for multiple types of intraclass correlation coefficients among the observations in each cluster, we derive the closed-form joint distribution of K treatment effect estimators to facilitate sample size and power determination with different types of null hypotheses under equal cluster sizes. We characterize the relationship between the power of each test and different types of correlation parameters. We further relax the equal cluster size assumption and approximate the joint distribution of the K treatment effect estimators through the mean and coefficient of variation of cluster sizes. Our simulation studies with a finite number of clusters indicate that the predicted power by our method agrees well with the empirical power, when the parameters in the MLMM are estimated via the expectation-maximization algorithm. An application to a real CRT is presented to illustrate the proposed method.",
keywords = "coefficient of variation, general linear hypothesis, intersection-union test, multivariate linear mixed model, sample size determination, unequal cluster size",
author = "Siyun Yang and Mirjam Moerbeek and Monica Taljaard and Fan Li",
note = "Funding Information: Research in this article was supported by a Patient‐Centered Outcomes Research Institute Award (PCORI Award ME‐2020C3‐21072), as well as by the National Institute of Aging (NIA) of the National Institutes of Health (NIH) under Award Number U54AG063546, which funds NIA Imbedded Pragmatic Alzheimer's Disease and AD‐Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory). The statements presented are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors or Methodology Committee, or the National Institutes of Health. The authors thank the associate editor and two anonymous referees for their constructive comments, which greatly helped improve the exposition of our work. {\textregistered} {\textregistered} {\textregistered} Funding Information: Research in this article was supported by a Patient-Centered Outcomes Research Institute Award{\textregistered} (PCORI{\textregistered} Award ME-2020C3-21072), as well as by the National Institute of Aging (NIA) of the National Institutes of Health (NIH) under Award Number U54AG063546, which funds NIA Imbedded Pragmatic Alzheimer's Disease and AD-Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory). The statements presented are solely the responsibility of the authors and do not necessarily represent the views of PCORI{\textregistered}, its Board of Governors or Methodology Committee, or the National Institutes of Health. The authors thank the associate editor and two anonymous referees for their constructive comments, which greatly helped improve the exposition of our work. Publisher Copyright: {\textcopyright} 2022 The Authors. Biometrics published by Wiley Periodicals LLC on behalf of International Biometric Society.",
year = "2023",
month = jun,
doi = "10.1111/biom.13692",
language = "English",
volume = "79",
pages = "1293--1305",
journal = "Biometrics",
issn = "0006-341X",
publisher = "Wiley-Blackwell",
number = "2",
}